Skip to main content

5 Result(s)

within J C Ianotto Remove this filter

and

  1. Article

    Open Access

    Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP

    Aquagenic pruritus (AP), an intense sensation of scratching induced after water contact, is the most troublesome aspect of BCR-ABL1-negative myeloproliferative neoplasms (MPNs). Mostly described in polycythemi...

    C. Le Gall-Ianotto, R. Verdet, E. Nowak, L. Le Roux, A. Gasse, A. Fiedler… in Trials (2021)

    Download PDF (1038 KB) View Article

  2. No Access

    Article

    Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study

    A high number of circulating CD34+ cells has been advocated to distinguish primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms. We re-evaluated the diagnostic interest of measur...

    C. Orvain, D. Luque Paz, I. Dobo, L. Cottin, G. Le Calvez… in Annals of Hematology (2016)

  3. No Access

    Article

    Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

    X Cabagnols, J P Defour, V Ugo, J C Ianotto, P Mossuz, J Mondet, F Girodon… in Leukemia (2015)

  4. No Access

    Article

    Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients

    J-C Ianotto, A Tempescul, X Yan, P Delepine, R Le Calloch… in Bone Marrow Transplantation (2012)

  5. No Access

    Article

    ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin’s lymphoma relapsing after autologous stem cell transplantation

    A. Tempescul, J. C. Ianotto, J. R. Eveillard, G. Guillerm… in Annals of Hematology (2011)